|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 26, 2015 ) The report covers the present scenario and the growth prospects of the global neurostimulation devices market for the period 2015-2019. Based on devises, the market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others.
The report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global neurostimulation devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson's disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug therapy or surgery is not effective.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The analysts forecast the global neurostimulation devices market to grow at a CAGR of 5.37% over the period 2014-2019.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=393310 .
Key Regions
Americas
APAC
EMEA
Key Vendors
Boston Scientific
Cyberonics
Medtronic
St. Jude Medical
Other Prominent Vendors
Aleva Neurotherapeutics
Atrotech
Autonomic Technologies
ElectroCore
Endostim
EnteroMedics
ImThera Medical
Inspire Medical Systems
Neuros Medical
NeuroMetrix
NeuroPace
NeuroSigma
Nevro
SPR Therapeutics
Synapse Biomedical
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=393310 .
Market Driver
Rise in Prevalence of Neurological Disorders
Market Challenge
Not First Line of Treatment Therapy
Market Trend
Significant Increase in Product Development and Launches
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=393310 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
